NCT00469196View on ClinicalTrials.gov

Tomotherapy Treatment for Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Mesothelioma
Interventions
PROCEDURE

Tomotherapy

40 Gy in 15 fractions, at one fraction per day. Dose will be prescribed to the 95% isodose line.

Trial Locations (1)

T5N 2R8

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER

NCT00469196 - Tomotherapy Treatment for Mesothelioma | Biotech Hunter | Biotech Hunter